Home/News/Details

South Korea Proposes to Revise the Guideline for the Management of Cosmetic Labeling and Advertising

Nov 10, 2026
Korea
Favorites
Share
Unlock exclusive content and benefits? Sign up for free today!

On November 4, 2026, the Ministry of Food and Drug Safety (MFDS) of South Korea issued the draft revision of the Guideline for the Management of Cosmetic Labeling and Advertising; the Korea Cosmetics Association (KCIA) forwarded it to enterprises for comments on November 5. The comment period closed on November 9, 2026.

Background 

By listing examples of prohibited expressions in labeling and advertising and specifying the main targets of substantiation data requirements, the guideline provides a basis for judgment for cosmetic manufacturers, responsible cosmetic sellers, sellers of customized cosmetics, and sellers. The current version is the 10th edition issued on August 14, 2025.

It should be noted that this document is a guideline compiled by Korea’s MFDS for enterprises and does not have legally binding force; expressions such as “shall””in the text are for reference only. However, the examples listed therein have become, in practice, an important basis for determining whether labeling or advertising violates Article 13 of the Cosmetics Act.

Main Revisions

Centering on supplementing examples of prohibited expressions and substantiation targets, this revision can be summarized in three aspects:

  • Expanding the examples of prohibited expressions in Appendix 1 “Scope and Criteria of Expressions for Cosmetic Labeling and Advertising”, covering categories such as disease names, body improvement, medical aesthetic procedures, ingredients and human-derived ingredients, methods of use, and adult products;
  • Adding sun protection factor-related labeling to Appendix 2 “Main Targets of Substantiation for Cosmetic Labeling and Advertising”;
  • Adding a note on the method for labeling the content or concentration of ingredients.

Appendix 1: 4 Categories of Expansion

Appendix 1 lists prohibited expressions under item 1, item 2, and item 4 of Paragraph 1 of Article 13 of the Cosmetics Act.

1. Expansion of Prohibited Expressions Related to Disease Names

Under item 1 (relating to disease diagnosis, treatment, alleviation, handling, prevention, and medical efficacy and effects), a new column of “names of other diseases” has been added, expressly listing the following disease names as prohibited expressions:

  • senile warts, condyloma acuminatum, athlete’s foot, tinea capitis, rhinitis, warts, skin tags, seborrheic scalp dermatitis, vaginitis, herpes, etc.

2. Expressions Related to Body Improvement, Medical Aesthetic Procedures, and Medical Devices

Under the “body improvement expressions” of item 1, the entry “facial contour improvement, V-line” has been expanded to “facial contour improvement, V-line, double chin improvement, and mid-face reduction””.

Under item 4 (relating to designation or official recognition by specific persons or institutions), the examples of “advertising beyond the scope of cosmetics” have been expanded as follows:

  • The entry “Botox” now additionally includes “Skin Tox (Skinvive, an injectable product for skin improvement)”;
  • The entry “expressions related to procedures such as laser and Carboxy” now additionally includes “Juvelook (an injectable filler product)”;
  • A new entry of “expressions related to medical devices (Medical Device, MD)” has been added.

3. Ingredients, Human-derived Ingredients, and Narcotic-class Ingredients

Under item 2 (relating to functional cosmetics), the example of “ingredient-related expressions” has been expanded from “ingredient XX with anti-wrinkle effects” to “ingredient XX with anti-wrinkle effects, highly functional ingredient XX”, bringing generalized characterizations such as “highly functional” into the examples liable to cause misperception of functionality.

Under the “human-derived ingredient-related expressions” of item 4, the examples of specific ingredients liable to cause misperception have been expanded from “exosomes, liposomes, etc.” to “exosomes, liposomes, ECM, etc.”, with “ECM cosmetics, ECM” added under the examples.

A new entry has been added: for ingredients classified as narcotics under the Act on the Control of Narcotics, etc. that must not be added to cosmetics (tetrahydrocannabinol (THC), cannabidiol (CBD), etc.), expressions indicating their names or contents constitute prohibited expressions even where they are naturally present in trace amounts.

4.  Expressions Related to Methods of Use and Adult Products

Under “expressions contrary to facts or liable to mislead consumers”, the entries of “topical application” and “topical vaginal lactic acid bacteria” have been added.

Appendix 2: Sun Protection Factors Newly Added as Substantiation Targets

Three items have been newly added:

  • Sun protection factor (SPF);
  • Water-resistant sun protection factor (SPF, water resistance, or persistent water resistance);
  • Ultraviolet A protection grade (PA).

The means of substantiation are to rely on the basis already contained in the examination data of the sun-protection functional cosmetic that has undergone examination, or to separately submit substantiation data for the function (data of human application tests or in vitro tests). Appendix 2 also reiterates that substantiation targets are not limited to the items listed in the table, and that substantiation data may be requested for any labeling or advertising relating to facts.

Labeling Method: Criteria for Labeling the Content and Concentration of Ingredients

A new note has been added: when labeling or advertising the content or concentration of an ingredient, the finished product shall be used as the basis and the unit of the content or concentration shall be indicated, so as to reduce consumer misperception; when indicating units below parts per million (ppm, ppb, etc.), it is recommended to indicate the percentage (%) in parallel.

This requirement dovetails with the existing rules for labeling extract content (based on the finished product and excluding the content of extraction and dilution solvents; where the solvent ratio is difficult to confirm, “containing extraction solvent” must be indicated).

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Our Services

  • South Korea Cosmetics Product Notification & Registration (General Cosmetics, Functional Cosmetics)
  • South Korea Cosmetic Ingredient Database (KCID) Registration
  • South Korea Responsible Party (RP) Services
  • South Korea Cosmetic Formula Review
  • South Korea Cosmetic Label Review
  • Quality Inspection

Further Information:

South Korea KCIA

GlobalCosing Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: GlobalCosing" on this website are copyrighted by GlobalCosing. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: GlobalCosing" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: GlobalCosing" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on GlobalCosing raises copyright or other related issues, please contact us within two weeks.

4. CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. GlobalCosing is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS’s current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.

Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
4.
CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. GlobalCosIng is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS's current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.